Home
Company
Platform Technology
Products
Newsroom
Jobs
Contact
More
Easily accessible and ready to use kits, including materials of natural or synthetic origin based on a variety of crosslinking strategies will address your needs and lead your experiments on cymatiX® to success.
MimiX Biotherapeutics Appoints Accomplished Industry Leader, André Kobelt, to Its Board of Directors
Press release: PreComb and mimiX announce co-operation to reshape personalized cancer drug profiling
mimiX biotherapeutics launches a funding round to accelerate clinical translation of FastSkin®
mimiX Biotherapeutics
Co/Switzerland Innovation Park
Aarbergstrasse 46
2503 Biel/Bienne
Switzerland
Thanks for your interest in cymatiX. Our Business development team will contact you soon.
Looking forward pushing the frontiers of biofabrication together!